Horizon Therapeutics is a global biotechnology company driven by the belief that science and compassion must work hand in hand to transform lives. With a mission to provide medicines for rare, autoimmune, and severe inflammatory diseases, they are committed to making a meaningful difference for patients and communities in need. The company was founded in 2008, but its story begins with CEO Tim Walbert's personal journey.

Diagnosed with an autoimmune condition during college and later with a rare disease after a decade of seeing physicians, Walbert's investment in Horizon goes beyond business – it is deeply personal. Despite its growth, Horizon maintains the same culture it started with. The company has over 2,000 employees worldwide and collaborates with more than 100 patient advocacy groups and 60+ community partners.

Their scientific courage is fueled by the experiences of caregivers and patients who grapple with diseases lacking widespread understanding and treatment. Horizon also recognizes its responsibility to give back to the communities where they operate. In addition to their innovative research and development, they actively support the well-being of their patient communities and local areas.

For those seeking more information about their medicines and commitment to patients, Horizon Therapeutics offers comprehensive resources on their website